Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer. (Q46469685)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

P G Alfonso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E Pujol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

E González

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

C Castañon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

P Cerezuela

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Y López-Mateos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J J Cruz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

243-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

11 January 2020

cites work

1 reference

12 December 2020

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

1 reference

12 December 2020

Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer

1 reference

12 December 2020

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma

1 reference

12 December 2020

Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers.

1 reference

12 December 2020

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

12 December 2020

UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients

1 reference

12 December 2020

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

12 December 2020

The prodrugs of 5-fluorouracil

1 reference

12 December 2020

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.

1 reference

12 December 2020

Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.

1 reference

12 December 2020

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

12 December 2020

Where do we stand with 5-fluorouracil?

1 reference

12 December 2020

Oral tegafur-uracil plus leucovorin in metastatic colorectal cancer: clinical insights. Proceedings of a roundtable expert meeting. October 2002, Nice, France

1 reference

12 December 2020

Advanced colorectal cancer treatment in Europe: what have we achieved?

1 reference

12 December 2020

A two-stage design for choosing among several experimental treatments and a control in clinical trials

1 reference

12 December 2020

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

12 December 2020

A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).

1 reference

12 December 2020

A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer

1 reference

12 December 2020

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer

1 reference

12 December 2020

Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents

1 reference

12 December 2020

Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

1 reference

12 December 2020

UFT in the treatment of colorectal and breast cancer

1 reference

12 December 2020

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

1 reference

12 December 2020

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

12 December 2020

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

12 December 2020

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

1 reference

12 December 2020

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

1 reference

12 December 2020

Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study

1 reference

12 December 2020

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

12 December 2020

Uracil-ftorafur: an oral fluoropyrimidine active in colorectal cancer

1 reference

12 December 2020

Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer

1 reference

12 December 2020

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

12 December 2020

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin

1 reference

12 December 2020

Metastatic colorectal cancer: systemic treatment in the new millennium

1 reference

12 December 2020

A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer

1 reference

12 December 2020

10.1007/S10637-005-6733-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15868381%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference